Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2

J Biol Chem. 2005 Aug 12;280(32):28848-51. doi: 10.1074/jbc.C500200200. Epub 2005 Jun 26.

Abstract

The Kruppel-like factor KLF2 was recently identified as a novel regulator of endothelial pro-inflammatory and pro-thrombotic function. Here it is shown that overexpression of KLF2 potently inhibits vascular permeability factor/vascular endothelial growth factor (VEGF-A)-mediated angiogenesis and tissue edema in the nude ear mouse model of angiogenesis. In vitro, KLF2 expression retards VEGF-mediated calcium flux, proliferation and induction of pro-inflammatory factors in endothelial cells. This effect is due to a potent inhibition of VEGFR2/KDR expression and promoter activity. These observations identify KLF2 as a regulator of VEGFR2/KDR and provide a foundation for novel approaches to regulate angiogenesis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenoviridae / genetics
  • Animals
  • Blotting, Western
  • Calcium / metabolism
  • Cell Nucleus / metabolism
  • Cell Proliferation
  • Cells, Cultured
  • Endothelium, Vascular / cytology
  • Green Fluorescent Proteins / metabolism
  • Humans
  • Inflammation
  • Kruppel-Like Transcription Factors
  • Male
  • Mice
  • Mice, Nude
  • Neovascularization, Pathologic*
  • Thrombosis
  • Time Factors
  • Trans-Activators / metabolism*
  • Transfection
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*
  • Zinc Fingers

Substances

  • KLF2 protein, human
  • Klf2 protein, mouse
  • Kruppel-Like Transcription Factors
  • Trans-Activators
  • Vascular Endothelial Growth Factor A
  • Green Fluorescent Proteins
  • Calcium